Search

everythinglearnresearchcommunity

for

Search:↓

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

The compound was successfully made and shows potential for treating prostate cancer.

New progesterone-based compounds can block male hormones.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Some steroid-induced health issues in rodents improved after stopping treatment, but hair loss and eye problems did not.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

Biochanin A from soy is a promising and safe candidate for treating hair loss.

Girard's reagent P improves detection of spironolactone and its metabolites.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Finasteride blocks progesterone production in specific tumor cells, potentially causing side effects.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, and antioxidants may help treat hair loss.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

More body hair in young Australian women is linked to higher androstenedione levels.

Ursolic acid from Ochrosia elliptica leaves may help manage PCOS symptoms.

Clascoterone safely promotes hair growth similar to minoxidil.

Surgical removal of a rare ovarian tumor improved symptoms and hormone levels in a postmenopausal woman.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

Certain hormone levels can help diagnose P450 oxidoreductase deficiency.

Mutations in certain receptors can cause diseases and offer new treatment options.